Cite
MLA Citation
Diwakar Davar et al.. “394 Interleukin-8–neutralizing monoclonal antibody BMS-986253 plus nivolumab (NIVO) in biomarker-enriched, primarily anti–PD-(L)1–experienced patients with advanced cancer: initial phase 1 results.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A419. http://access.bl.uk/ark:/81055/vdc_100144731137.0x000002